Peter Langguth

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 5

Top Topics

Magnetic Resonance

Top Venues

Pulmonary therapy

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Herbert Wachtel, Rachel Emerson-Stadler, Peter Langguth, Jens M Hohlfeld, Jill A Ohar
Aerosol Plumes of Inhalers Used in COPD. Pulmonary therapy 10 (1) (2024)
Herbert Wachtel, Rachel Emerson-Stadler, Peter Langguth, Jens M Hohlfeld, Jill A Ohar
Aerosol Plumes of Inhalers Used in COPD. Pulmonary therapy 10 (1) (2024)
Herbert Wachtel, Rachel Emerson-Stadler, Peter Langguth, Jens M Hohlfeld, Jill A Ohar
Aerosol Plumes of Inhalers Used in COPD. Pulmonary therapy (2024)
Jozef Al-Gousous, Yasuhiro Tsume, Maoqi Fu, Isam I Salem, Peter Langguth
Unpredictable Performance of pH-Dependent Coatings Accentuates the Need for Improved Predictive in Vitro Test Systems. Molecular pharmaceutics 14 (12) (2017)
David Dahlgren, Carl Roos, Anders Lundqvist, Christer Tannergren, Peter Langguth, Markus Sjöblom, Erik Sjögren, Hans Lennernäs
Preclinical Effect of Absorption Modifying Excipients on Rat Intestinal Transport of Model Compounds and the Mucosal Barrier Marker 51Cr-EDTA. Molecular pharmaceutics 14 (12) (2017)